Malaria's Pragmatic Approach to Gene Expression

Amosquito alights on a human victim and pierces the skin, injecting its salivary mixture of anticoagulants to make blood flow smoothly while feeding.

Written byIshani Ganguli
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

© Dr. Gary Gaugler/Science Photo Library

A mosquito alights on a human victim and pierces the skin, injecting its salivary mixture of anticoagulants to make blood flow smoothly while feeding. At least 300 million times each year, that mixture comes with unwanted travelers: Plasmodium sporozoites, once inside a human host, invade the liver, maturing until ready to wreak havoc on its victim's red blood cells.

Understanding malaria's complex life cycle remains as challenging to researchers as it is critical for public health. The global killer is difficult to culture, and traditional genetic and biochemical tools are largely ineffective. In 2002 an international consortium published the 26 Mb genome of Plasmodium falciparum, the deadliest malaria species.1 Overcoming significant technical obstacles, the sequence represented an "entry into the biology of the parasite," says Philip Rosenthal at San Francisco General Hospital. Still, 60% of P. falciparum's nearly 5,500 predicted genes had no known ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies